Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15,259 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Methylene tetrahydrofolate reductase genotype modifies the chemopreventive effect of folate in colorectal adenoma, but not colorectal cancer.
Lightfoot TJ, Barrett JH, Bishop T, Northwood EL, Smith G, Wilkie MJ, Steele RJ, Carey FA, Key TJ, Wolf R, Forman D. Lightfoot TJ, et al. Among authors: smith g. Cancer Epidemiol Biomarkers Prev. 2008 Sep;17(9):2421-30. doi: 10.1158/1055-9965.EPI-08-0058. Epub 2008 Aug 14. Cancer Epidemiol Biomarkers Prev. 2008. PMID: 18703816
Polymorphisms in the cytochrome P450 CYP1A2 gene (CYP1A2) in colorectal cancer patients and controls: allele frequencies, linkage disequilibrium and influence on caffeine metabolism.
Sachse C, Bhambra U, Smith G, Lightfoot TJ, Barrett JH, Scollay J, Garner RC, Boobis AR, Wolf CR, Gooderham NJ; Colorectal Cancer Study Group. Sachse C, et al. Among authors: smith g. Br J Clin Pharmacol. 2003 Jan;55(1):68-76. doi: 10.1046/j.1365-2125.2003.01733.x. Br J Clin Pharmacol. 2003. PMID: 12534642 Free PMC article.
No evidence that polymorphisms in CYP2C8, CYP2C9, UGT1A6, PPARdelta and PPARgamma act as modifiers of the protective effect of regular NSAID use on the risk of colorectal carcinoma.
McGreavey LE, Turner F, Smith G, Boylan K, Timothy Bishop D, Forman D, Roland Wolf C, Barrett JH; Colorectal Cancer Study Group. McGreavey LE, et al. Among authors: smith g. Pharmacogenet Genomics. 2005 Oct;15(10):713-21. doi: 10.1097/01.fpc.0000174786.85238.63. Pharmacogenet Genomics. 2005. PMID: 16141797
Genetic variants in XRCC2: new insights into colorectal cancer tumorigenesis.
Curtin K, Lin WY, George R, Katory M, Shorto J, Cannon-Albright LA, Smith G, Bishop DT, Cox A, Camp NJ; Colorectal Cancer Study Group. Curtin K, et al. Among authors: smith g. Cancer Epidemiol Biomarkers Prev. 2009 Sep;18(9):2476-84. doi: 10.1158/1055-9965.EPI-09-0187. Epub 2009 Aug 18. Cancer Epidemiol Biomarkers Prev. 2009. PMID: 19690184 Free PMC article.
Interaction between polymorphisms in aspirin metabolic pathways, regular aspirin use and colorectal cancer risk: A case-control study in unselected white European populations.
Sheth H, Northwood E, Ulrich CM, Scherer D, Elliott F, Barrett JH, Forman D, Wolf CR, Smith G, Jackson MS, Santibanez-Koref M, Haile R, Casey G, Jenkins M, Win AK, Hopper JL, Marchand LL, Lindor NM, Thibodeau SN, Potter JD, Burn J, Bishop DT. Sheth H, et al. Among authors: smith g. PLoS One. 2018 Feb 9;13(2):e0192223. doi: 10.1371/journal.pone.0192223. eCollection 2018. PLoS One. 2018. PMID: 29425227 Free PMC article.
15,259 results
You have reached the last available page of results. Please see the User Guide for more information.